Search research articles
Contact Us
Filters
Showing results (1-10 of 37) with videos related to
Page
of 4
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
June 18, 1999
Relative versus attributable risk of breast cancer from estrogen replacement therapy
R J Santen, G R Petroni
Biometrics
|
June 1, 1995
Bivariate sequential designs for phase II trials
M R Conaway, G R Petroni
Biometrics
|
December 1, 1996
Designs for phase II trials allowing for a trade-off between response and toxicity
M R Conaway, G R Petroni
Biometrics
|
March 1, 1994
A two-sample test for stochastic ordering with interval-censored data
G R Petroni, R A Wolfe
Urology
|
May 1, 1999
Urinary function after radical prostatectomy: a comparison of the retropubic and perineal approaches
M Gray, G R Petroni, D Theodorescu
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 25, 2016
Statistical controversies in clinical research: early-phase adaptive design for combination immunotherapies
N A Wages, C L Slingluff, G R Petroni
The Journal of Clinical Endocrinology and Metabolism
|
March 7, 2001
Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy
R J Santen, J Pinkerton, C McCartney, et al.
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
Quality of life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer
T Krupski, G R Petroni, E A Bissonette, et al.
Urology
|
May 3, 2000
Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer
T Krupski, G R Petroni, E A Bissonette, et al.
Urology
|
May 3, 2000
Microvessel density, p53, retinoblastoma, and chromogranin A immunohistochemistry as predictors of disease-specific survival following radical prostatectomy for carcinoma of the prostate
T Krupski, G R Petroni, H F Frierson, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 37) with videos related to
Sort By:
Page
of 4
The Journal of Clinical Endocrinology and Metabolism
|
June 18, 1999
Relative versus attributable risk of breast cancer from estrogen replacement therapy
R J Santen, G R Petroni
Biometrics
|
June 1, 1995
Bivariate sequential designs for phase II trials
M R Conaway, G R Petroni
Biometrics
|
December 1, 1996
Designs for phase II trials allowing for a trade-off between response and toxicity
M R Conaway, G R Petroni
Biometrics
|
March 1, 1994
A two-sample test for stochastic ordering with interval-censored data
G R Petroni, R A Wolfe
Urology
|
May 1, 1999
Urinary function after radical prostatectomy: a comparison of the retropubic and perineal approaches
M Gray, G R Petroni, D Theodorescu
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 25, 2016
Statistical controversies in clinical research: early-phase adaptive design for combination immunotherapies
N A Wages, C L Slingluff, G R Petroni
The Journal of Clinical Endocrinology and Metabolism
|
March 7, 2001
Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy
R J Santen, J Pinkerton, C McCartney, et al.
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
Quality of life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer
T Krupski, G R Petroni, E A Bissonette, et al.
Urology
|
May 3, 2000
Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer
T Krupski, G R Petroni, E A Bissonette, et al.
Urology
|
May 3, 2000
Microvessel density, p53, retinoblastoma, and chromogranin A immunohistochemistry as predictors of disease-specific survival following radical prostatectomy for carcinoma of the prostate
T Krupski, G R Petroni, H F Frierson, et al.
Page
of 4